If you could vote on Brexit now which option would you choose?
   

Japan's Chugai soars nearly 6% after UK says its drug reduces hospital time for Covid patients


The U.K. government said patients receiving the drugs, typically used to treat rheumatoid arthritis, “left intensive care between 7 to 10 days earlier on average.” A government-funded clinical trial showed tocilizumab was among two drugs that “reduced the relative risk of death by 24% when administered to patients within 24 hours of entering intensive care.” Shares of Chugai closed 5.91% higher on Tuesday. Earlier in the session, Chugai’s stock soared as much as 16.26%.

CNBC - January 12, 2021

View the full story here: https://www.cnbc.com/2021/01/12/chugai-soars-after-uk-says-its-drug-is-effective-for-covid-treatment.html